Pioglitazone — a drug used to treat Type 2 diabetes — is associated with an increased risk of bladder cancer, finds a study published on bmj.com today.
Diabetes Drug Linked To Increased Risk Of Bladder Cancer
Related posts:
- Lawsuits Allege Actos Drug Linked To Increased Bladder Cancer Risk Climaco, Wilcox, Peca, Tarantino & Garofoli Co., LPA has filed...
- Actos Linked To Increased Risk Of Bladder Cancer Recent Studies by the Food and Drug Administration as well...
- FDA Warns Diabetes Drug Actos Linked To Bladder Cancer Risk The FDA updates its warning on the increased risk of...
- Diabetes Drug Linked To Bladder Cancer Moreover, the medication guide of the patient with the medication...
- Did You Know Diabetes Drug Actos Has Been Linked To Bladder Cancer Many people taking the diabetes medication, Actos, may not realize...